| USD billions | FY2024 | FY2025 | TTM |
|---|---|---|---|
| Revenue | 1.2 | 1.5 | 1.9 |
| Cost of revenue | 1.2 | 1.4 | 1.7 |
| Gross profit | 0.1 | 0.1 | 0.2 |
| Research & development | 0.0 | 0.0 | — |
| Operating expenses | 0.1 | 0.1 | 0.1 |
| Operating income | (0.0) | 0.0 | 0.1 |
| Interest expense | 0.1 | 0.1 | 0.1 |
| Interest income | 0.0 | 0.0 | 0.0 |
| Pre-tax income | (0.0) | 0.0 | 0.0 |
| Income tax | (0.0) | 0.0 | 0.0 |
| Net income | (0.0) | 0.0 | 0.0 |
| EPS, basic (per share) | (0.53) | 0.03 | 0.41 |
| EPS, diluted (per share) | (0.53) | 0.03 | 0.41 |
| EBITDA | 0.0 | 0.1 | — |
| Depreciation & amortization | 0.1 | 0.1 | — |
| Weighted average shares (shares) | 77,444,152 | 77,444,152 | — |
| Weighted average diluted shares (shares) | 77,444,152 | 77,444,152 | — |
| Gross margin | 4.3% | 6.6% | 8.4% |
| Operating margin | −2.1% | 1.4% | 4.9% |
| Net margin | −3.4% | 0.2% | 1.7% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-03-31 and uses four consecutive reported quarters.